Newark, Del.
Incyte Genomics Inc., based in Palo Alto, Calif., will move into 53,100 sf at DuPont’s Stine-Haskell Research Center in Newark while the biotech company searches for a permanent East Coast facility for its therapeutic discovery and development work. Incyte hopes to secure approximately 90,000 sf of research, lab, and office space to accommodate 140 R&D staff in the next two years, and a total of 200 employees by 2005. Biotech and pharmaceutical companies, as well as research and academic institutions, use Incyte’s genomics technologies and products.
